Kaliumchlorid Noridem

Potassium chloride, the active ingredient in Kaliumchlorid Noridem, is an electrolyte supplement presented as a solution for injection for intravenous use. It treats hypokalemia and other conditions involving potassium depletion in hospitalized patients.

GNH USA supplies Kaliumchlorid Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kaliumchlorid Noridem is used to correct potassium deficits and restore electrolyte balance in clinical settings.

- Hypokalemia: restores normal serum potassium levels in patients with low potassium. - Potassium depletion: replenishes potassium stores after losses due to diuretics, gastrointestinal loss, or surgery. - Electrolyte replacement: provides a rapid intravenous source of potassium during acute care or peri‑operative management.

Kaliumchlorid Noridem may cause adverse reactions ranging from mild to severe.

Common Side Effects: - Injection site pain: discomfort or tenderness at the infusion site. - Nausea: mild gastrointestinal upset following administration. - Dizziness or headache: transient sensations of light‑headedness.

Serious or Rare Side Effects: - Severe hyperkalemia: dangerously high serum potassium leading to cardiac arrhythmia. - Anaphylactic reaction: rare hypersensitivity with rash, swelling, or respiratory distress. - Venous thrombosis: clot formation at the infusion site.

Use Kaliumchlorid Noridem with careful clinical monitoring to avoid complications.

- Serum potassium monitoring: check levels before, during, and after infusion. - Renal impairment: adjust infusion rate or dose in patients with reduced kidney function. - Cardiac disease: avoid rapid infusion in patients with known arrhythmias. - Concomitant potassium‑sparing agents: limit total potassium load. - Infusion rate: administer over the recommended time to prevent sudden shifts. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Potassium chloride can interact with several medications that affect potassium balance.

Major Interactions (Avoid): - ACE inhibitors or ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of excessive potassium. - NSAIDs: can reduce renal potassium excretion. - Trimethoprim: potentiates hyperkalemia. - Cyclosporine: may impair potassium handling.

Moderate Interactions (Monitor Closely): - Digoxin: hyperkalemia can enhance digoxin toxicity. - Beta‑blockers: monitor cardiac function with elevated potassium. - Insulin therapy: insulin shifts potassium intracellularly; monitor levels. - Other IV fluids containing potassium: avoid cumulative excess. - Corticosteroids: may alter electrolyte balance, requiring observation.